Plüss H J, Joller P W, Hitzig W H
Schweiz Med Wochenschr. 1981 Oct 10;111(41):1527-9.
Of 58 children with acute lymphatic leukemia who had undergone marker studies of blasts, only 6 (10%) had greater than 30 E+ blasts. Of these, 5 had a high WBC and organomegaly, but only 2 suffered a fatal course. Two more have been in CCR for over 5 years despite other risk factors. Patients with less than 30% E+ cells did not differ from common ALL patients clinically or in their response to treatment. However, 3 older children with Hp-positive but E negative blasts had a very high WBC and died without having remission. Only standardized marker studies, treatment and follow-up of a large series of ALL patients will show the importance to be attached to these and other T-cell markers compared with the better-known clinical and hematologic risk factors.
在58例接受原始细胞标记研究的急性淋巴细胞白血病患儿中,只有6例(10%)原始细胞E+大于30%。其中,5例白细胞计数高且有器官肿大,但只有2例病程致命。另有2例尽管存在其他危险因素,但已持续完全缓解超过5年。E+细胞少于30%的患者在临床或对治疗的反应方面与普通急性淋巴细胞白血病患者无异。然而,3例年龄较大、原始细胞Hp阳性但E阴性的患儿白细胞计数非常高,未缓解即死亡。只有对大量急性淋巴细胞白血病患者进行标准化的标记研究、治疗和随访,才能显示出与更知名的临床和血液学危险因素相比,这些及其他T细胞标记的重要性。